Get startedLog in
    Picture of Britannia Life Sciences logo

    BLAB — Britannia Life Sciences Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Britannia Life Sciences, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

    2019
    November 30th
    2020
    November 30th
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-7.13-3.2-145.84-4.4
    Depreciation
    Deferred Taxes
    Non-Cash Items1.692.1816.1-4.455.34
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.720.750.461-0.4150.885
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-7.11-0.2072.81.222.09
    Capital Expenditures-0.0680-0.087-0.342-0.337
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0—0.741-2.98-1.1
    Acquisition of Business
    Sale of Business
    Purchase of Investments
    Cash from Investing Activities-0.06800.654-3.32-1.44
    Financing Cash Flow Items—1.93-0.5960-1.8
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities3.550.022-2.582.95-1.97
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3.62-0.1850.8030.967-1.28